A cure for nasopharyngeal cancer is getting closer to reality. Home-grown firm Tessa Therapeutics is conducting what it says is the world's largest trial of its kind to treat patients through a specialised form of immunotherapy: virus-specific T-cell therapy. Jose Hong explains the science behind it.